BJ
XLRN

BlackRock Japan’s Acceleron Pharma XLRN Stock Holding History

BlackRock Japan’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-221
Closed -$8K – 1404
2016
Q3 		$8K Buy
221
+127
+135% +$4.21K ﹤0.01% 1230
2016
Q2 		$3K Buy
+94
New +$3.06K ﹤0.01% 1390
2016
Q1 		– Sell
-88
Closed -$4K – 1502
2015
Q4 		$4K Buy
+88
New +$3.17K ﹤0.01% 1346
2014
Q2 		– Sell
-5,082
Closed -$175K – 1432
2014
Q1 		$175K Buy
5,082
+2,134
+72% +$96.3K ﹤0.01% 962
2013
Q4 		$117K Buy
+2,948
New +$71.2K ﹤0.01% 1001

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BlackRock Japan's XLRN Position: Q4 2016 in Review

BlackRock Japan sold out of Acceleron Pharma (XLRN) in Q4 2016, closing a stake of 221 shares — an estimated $8K sold.

BlackRock Japan first reported a position in XLRN in Q4 2013 and held it in 5 quarters. The position peaked at $175K in Q1 2014. 146 funds tracked by Wall St. Rank hold XLRN as of Q4 2016.

  • BlackRock Japan reported no remaining Acceleron Pharma position as of Q4 2016 after selling out during the quarter.
  • BlackRock Japan sold 221 Acceleron Pharma shares in Q4 2016, an estimated $8K.
  • BlackRock Japan first reported a position in Acceleron Pharma in Q4 2013 and held it in 5 quarters.
  • BlackRock Japan's Acceleron Pharma position peaked at $175K in Q1 2014.
  • 146 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.